Sippican Capital Advisors Biogen Inc. Transaction History

Sippican Capital Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 20, 2021	SELL	$282.99 - $369.05 $403,543 - $526,265	-1,426 Closed	0 $0
Q2 2021 Jul 22, 2021	BUY	$259.0 - $414.71 $19,425 - $31,103	75 Added 5.55%	1,426 $494,000
Q1 2021 Apr 15, 2021	SELL	$242.95 - $284.63 $40,086 - $46,963	-165 Reduced 10.88%	1,351 $378,000
Q4 2020 Jan 21, 2021	BUY	$236.26 - $355.63 $68,515 - $103,132	290 Added 23.65%	1,516 $371,000
Q3 2020 Oct 23, 2020	SELL	$264.77 - $305.71 $202,019 - $233,256	-763 Closed	0 $0
Q2 2020 Jul 15, 2020	BUY	$258.66 - $342.55 $197,357 - $261,365	763 New	763 $204,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Sippican Capital Advisors, based on Form 13F filings with the SEC.

Stay updated on Sippican Capital Advisors with notifications on news.